{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:41:21Z","timestamp":1760834481856,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jocn.2019.11.045","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T18:47:08Z","timestamp":1576522028000},"page":"185-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Seropositive neuromyelitis optica spectrum disorder in Emirati patients: A case series"],"prefix":"10.1016","volume":"72","author":[{"given":"Antonia","family":"Ceccarelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria Ann","family":"Mifsud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Dogar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Irteza","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2019.11.045_b0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis Spectrum Disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jocn.2019.11.045_b0010","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1212\/NXI.0000000000000134","article-title":"Update on biomarkers in neuromyelitis optica","volume":"2","author":"Melamed","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jocn.2019.11.045_b0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2019.11.045_b0020","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jamaneurol.2014.1581","article-title":"Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis","volume":"71","author":"Pittock","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jocn.2019.11.045_b0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1756285617709723","article-title":"Differential diagnosis of neuromyelitis optica spectrum disorders","volume":"10","author":"Kim","year":"2017","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jocn.2019.11.045_b0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"1511\u20131518","key":"10.1016\/j.jocn.2019.11.045_b0035","first-page":"e82","article-title":"Neuromyelitis optica: a positive appraisal of seronegative cases","volume":"22","author":"Bernard-Valnet","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2019.11.045_b0040","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2019.11.045_b0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1148\/rg.2018170141","article-title":"Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis","volume":"38","author":"Dutra","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.jocn.2019.11.045_b0050","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaneurol.2016.5441","article-title":"Association of extension of cervical cord lesion and area postrema syndrome with neuromyelitis optica spectrum disorder","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jocn.2019.11.045_b0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.25411","article-title":"Brain and cord imaging features in neuromyelitis optica spectrum disorders","volume":"85","author":"Cacciaguerra","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2019.11.045_b0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders. Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2019.11.045_b0065","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2019.11.045_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen3.12458","article-title":"Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study","volume":"9","author":"Holroyd","year":"2018","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.jocn.2019.11.045_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2019.11.045_b0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1352458516687043","article-title":"Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders","volume":"23","author":"Huh","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2019.11.045_b0085","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz144","article-title":"Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines","author":"Filippi","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2019.11.045_b0090","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3389\/fimmu.2017.01785","article-title":"Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica","volume":"8","author":"Wang","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jocn.2019.11.045_b0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.msard.2018.12.028","article-title":"Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases","volume":"28","author":"Bibic","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jocn.2019.11.045_b0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3174\/ajnr.A4539","article-title":"Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis","volume":"37","author":"Traboulsee","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jocn.2019.11.045_b0105","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1212\/WNL.0000000000005256","article-title":"Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD","volume":"90","author":"Cortese","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jocn.2019.11.045_b0110","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/nbm.3607","article-title":"Application of diffusional kurtosis imaging to detect occult brain damage in multiple sclerosis and neuromyelitis optica","volume":"29","author":"Qian","year":"2016","journal-title":"NMR Biomed"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819316807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586819316807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:22:14Z","timestamp":1760822534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586819316807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":22,"alternative-id":["S0967586819316807"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2019.11.045","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seropositive neuromyelitis optica spectrum disorder in Emirati patients: A case series","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2019.11.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}